KLRS

NASDAQ · Biotechnology

Kalaris Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.34

-0.01 (-0.12%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +174.5% upside

Low Target $19.41

Average Target $22.89

High Target $38.59

Current Price $8.34

Current
$8.34

Target
$22.89

$19.41 $22.89 avg $38.59

Scenario Analysis

Bear Case

$19.41

132.7%

Low target

Base Case

$22.89

+174.5%

Avg target

Bull Case

$38.59

+362.7%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$31.90

-73.9% from high

52-Week Low

$15.32

+-45.6% from low

Target vs 52W High

$22.89

-28.2% vs high

Next Earnings Report

Mar 5, 2026 · After Market Close

17d

until earnings

EPS Est: $-0.54

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%